Novavax (NVAX) Tops Q3 EPS by 1c
Tweet
Share
E-mailGet Alerts NVAX Hot Sheet
Price: $3.89 --0%
Revenue Growth %: +85.7%
Financial Fact:
Revenue: 102K
Today's EPS Names:
MAXN, CSTR, ACU, More
Revenue Growth %: +85.7%
Financial Fact:
Revenue: 102K
Today's EPS Names:
MAXN, CSTR, ACU, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q3 EPS of ($0.15), $0.01 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $8.4 million versus the consensus estimate of $6.42 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Schlumberger (SLB) earnings in-line, revenue beats expectations
- Lakeland Bancorp (LBAI) Tops Q1 EPS by 1c
- Senesco Technologies, Inc. (SNT) Reports Q1 EPS of $0.02
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
